In Vivo Activity Profiling of Biosynthetic Darobactin D22 against Critical Gram-Negative Pathogens.
Kany AM, Fries F, Seyfert CE, Porten C, Deckarm S, Chacón Ortiz M, Dubarry N, Vaddi S, Große M, Bernecker S, Sandargo B, Müller AV, Bacqué E, Stadler M, Herrmann J, Müller R.
Kany AM, et al. Among authors: herrmann j.
ACS Infect Dis. 2024 Nov 20. doi: 10.1021/acsinfecdis.4c00687. Online ahead of print.
ACS Infect Dis. 2024.
PMID: 39565008